The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Effects of inhaled glucocorticoids on bone density in premenopausal women.
Open accessAbstract
BACKGROUND: Inhaled glucocorticoids are the most commonly used medications for the long-term treatment of patients with asthma. Whether long-term therapy with inhaled glucocorticoids reduces bone mass, as oral glucocorticoid therapy does, is controversial. In a three-year prospective study, we examined the relation between the dose of inhaled glucocorticoids and the rate of bone loss in premenopausal women with asthma. METHODS: We studied 109 premenopausal women, 18 to 45 years of age, who had asthma and no known conditions that cause bone loss and who were treated with inhaled triamcinolone acetonide (100 microg per puff). We measured bone density by dual-photon absorptiometry at base line, at six months, and at one, two, and three years. Serum osteocalcin and parathyroid hormone and urinary N-telopeptide, cortisol, and calcium excretion were measured serially. We measured inhaled glucocorticoid use by means of monthly diaries, supported by the use of an automated actuator-monitoring device. RESULTS: Inhaled glucocorticoid therapy was associated with a dose-related decline in bone density at both the total hip and the trochanter of 0.00044 g per square centimeter per puff per year of treatment (P= 0.01 and P=0.005, respectively). No dose-related effect was noted at the femoral neck or the spine. Even after the exclusion of all women who received oral or parenteral glucocorticoids at any time during the study, there was still an association between the decline in bone density and the number of puffs per year of use. Serum and urinary markers of bone turnover or adrenal function did not predict the degree of bone loss. CONCLUSIONS: Inhaled glucocorticoids lead to a dose-related loss of bone at the hip in premenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most universally described skeletal consequence of glucocorticoid therapy is a reduction in BMD, which can lead to increased fracture risk (243-245).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [243]
In the citing paper
“the skeletal response to prednisolone in these rats shared several similarities to changes observed in humans, including significantly decreased BMD (243), histological evidence of increased bone resorption (194), and biochemical evidence of suppressed bone formation (244, 267, 268).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [243]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,997
J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,824
Bone density at various sites for prediction of hip fractures
Cummings, S. R., Browner, W., Cummings, S. R., Black, D. M., Nevitt, M. C., Browner, W., Genant, H. K., Cauley, J., Ensrud, K., Scott, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92555-8 · Cited by 2,446
Use of Inhaled Corticosteroids and Risk of Fractures
van Staa, T. P., Leufkens, H. G. M., & Cooper, C. C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,297
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Carey, V. J., Walters, E. E., Colditz, G. A., Solomon, C. G., Willet, W. C., Rosner, B. A., Speizer, F. E., & Manson, J. E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009158 · Cited by 827
Glucocorticoid-Induced Osteoporosis
Baylink, D. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090509 · Cited by 398
Inhaled corticosteroid use and bone-mineral density in patients with asthma
Wong, C., Walsh, L. J., Smith, C. J., Wisniewski, A. F. Z., Lewis, S., Hubbard, R., Cawte, S. A., Green, D. J., Pringle, M., & Tattersfield, A. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02138-3 · Cited by 361
Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss
Lukert, B. P., Johnson, B. E., & Robinson, R. G. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070909 · Cited by 211
Flagged first, then by citations
Research works printed but not linked: 3
- Packe GE, 1996, J R Coll Physicians Lond, 30, 128
- Egan JJ, 1999, Eur Respir J, 13, 1267
- Rich GM, 1992, J Heart Lung Transplant, 11, 950
Cited by
Sorted by citations
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Significant variability in response to inhaled corticosteroids for persistent asthma
Szefler, S. J., Martin, R. J., King, T. S., Boushey, H. A., Cherniack, R. M., Chinchilli, V. M., Craig, T., DOLOVICH, M. B., Drazen, J. M., Fagan, J. K., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122635 · Cited by 616
Self-citationFanta, C. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804579 · Cited by 405
Gibson, P. G., McDonald, V. M., & Marks, G. B. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61087-2 · Cited by 400
Guidelines of care for atopic dermatitis
Hanifin, J. M., Cooper, K. D., Ho, V. C., Kang, S., Krafchik, B. R., Margolis, D. J., Schachner, L. A., Sidbury, R., Whitmore, S. E., Sieck, C. K., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.08.003 · Cited by 392
Tao, S., Yuan, T., Rui, B., Zhu, Z., Guo, S., & Zhang, C. (2017) · Theranostics · doi:10.7150/thno.17450 · Cited by 345
MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
Mirza, F., & CANALIS, E. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0118 · Cited by 343
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Secondary Causes of Osteoporosis
FITZPATRICK, L. A. (2002) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62214-3 · Cited by 311
The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis
van Staa, T. P. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0019-1 · Cited by 257
Perspectives on glucocorticoid-induced osteoporosis
CANALIS, E. M., Bilezikian, J. P., Angeli, A., & Giustina, A. (2003) · Bone · doi:10.1016/j.bone.2003.11.026 · Cited by 244
Price, D. B. (2003) · Thorax · doi:10.1136/thorax.58.3.211 · Cited by 231
Allen, D. B., Bielory, L., Derendorf, H., Dluhy, R., Colice, G., & Szefler, S. J. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)01859-1 · Cited by 233
Exogenous cushing’s syndrome and glucocorticoid withdrawal
Hopkins, R. L., & Leinung, M. C. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.013 · Cited by 224
Tattersfield, A., Knox, A. J., Britton, J., & Hall, I. P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11312-2 · Cited by 217
Inhaled Corticosteroids and Hip Fracture: A Population-based Case–Control Study
Hubbard, R., Smith, C. J. P., Smeeth, L. L., Harrison, T. W., & Tattersfield, A. E. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-606oc · Cited by 193
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids
Deykin, A., Lazarus, S. C., Fahy, J. V., Wechsler, M. E., Boushey, H. A., Chinchilli, V. M., Craig, T., DiMango, E., Kraft, M., Leone, F. T., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.12.1129 · Cited by 191
Self-citationRubin, M. R., & Bilezikian, J. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-012101 · Cited by 191
Kelly, H. W., Natta, M. L. V., Covar, R. A., Tonascia, J. A., Green, R. P., & Strunk, R. C. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3381 · Cited by 189
Potential Adverse Effects of the Inhaled Corticosteroids
Kelly, H. W. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)01870-0 · Cited by 170
Pharmacological Management to Reduce Exacerbations in Adults With Asthma
Sin, D. D., Man, J., Sharpe, H. M., Gan, W., & Man, S. F. P. (2004) · JAMA · doi:10.1001/jama.292.3.367 · Cited by 168
Secondary Osteoporosis and Metabolic Bone Diseases
Sobh, M., Abdalbary, M., Elnagar, S., Nagy, E., Elshabrawy, N. A., Abdelsalam, M., Asadipooya, K., & El-Husseini, A. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092382 · Cited by 165
Buhl, R., Hanf, G., Solèr, M., Bensch, G. W., Wolfe, J., Everhard, F., Champain, K., Fox, H., & Thirlwell, J. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00016502 · Cited by 155
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
Kanis, J. A., Stevenson, M., McCloskey, E. V., Davis, S., & Lloyd-Jones, M. (2007) · Health Technology Assessment · doi:10.3310/hta11070 · Cited by 153
Glucocorticoid-induced osteoporosis
Saag, K. G. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00064-6 · Cited by 145
Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety
Price, D. B., Castro, M., BOURDIN, A. A., Fucile, S., & Altman, P. (2020) · European Respiratory Review · doi:10.1183/16000617.0151-2019 · Cited by 141
Secondary Osteoporosis: A Review of The Recent Evidence
Painter, S., Kleerekoper, M., & Camacho, P. M. (2006) · Endocrine Practice · doi:10.4158/ep.12.4.436 · Cited by 138
Gartlehner, G., Hansen, R., Carson, S., & Lohr, K. (2006) · Annals of Family Medicine · doi:10.1370/afm.517 · Cited by 136
Chung, K. F., Caramori, G., & Adcock, I. M. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0682-z · Cited by 128
Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II
Scanlon, P. D., Connett, J. E., Wise, R. A., Tashkin, D. P., Madhok, T. C., Skeans, M. A., Carpenter, P. C., Bailey, W. C., Buist, A. S., Eichenhorn, M. S., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1349oc · Cited by 126
Richy, F. F., Bousquet, J. J., Ehrlich, G. E., Meunier, P. J., Israel, E., Morii, H., Devogelaer, J., Peel, N. F. A., Haim, M., Bruyère, O., et al. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1398-z · Cited by 126
Self-citationGraat‐Verboom, L., Spruit, M. A., van den Borne, B. E. E. M., Smeenk, F. W. J. M., Martens, E. J., Lunde, R., & Wouters, E. F. �. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.02.014 · Cited by 123
Swanson, C., Lorentzon, M., Conaway, H. H., & Lerner, U. H. (2006) · Endocrinology · doi:10.1210/en.2005-0717 · Cited by 114
Effects of montelukast and beclomethasone on airway function and asthma control
Israel, E., Chervinsky, P., Friedman, B., van Bavel, J., Skalky, C. S., Ghannam, A. F., Bird, S. R., & Edelman, J. M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129413 · Cited by 113
Self-citationLee, C., Lee, M., Shu, C., Lim, C. S., Wang, J., Lee, L., & Chao, K. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-194 · Cited by 112
Disorders Associated With Acute Rapid and Severe Bone Loss
Epstein, S., Inzerillo, A. M., Caminis, J. N., & Zaidi, M. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2083 · Cited by 110
The Safety of Intranasal Steroids
Benninger, M. S., Ahmad, N., & Marple, B. F. (2003) · Otolaryngology · doi:10.1016/j.otohns.2003.10.001 · Cited by 110
Chu, E. K., & Drazen, J. M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200502-257oe · Cited by 104
Fracture Risk Associated with Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease
Lee, T. A., & Weiss, K. B. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-926oc · Cited by 104
Maintenance of asthma control by once‐daily inhaled ciclesonide in adults with persistent asthma
Chapman, K. R., Patel, P. M., D’Urzo, A. D., Alexander, M., Mehra, S., Oedekoven, C., Engelstätter, R., & Boulet, L. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00750.x · Cited by 103
Osteoporosis Associated with Excess Glucocorticoids
Shaker, J. L., & Lukert, B. P. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.014 · Cited by 100
Use of Inhaled Corticosteroids and the Risk of Fracture
Hubbard, R., Tattersfield, A. E., Smith, C., West, J., Smeeth, L. L., & FLETCHER, A. E. (2006) · CHEST Journal · doi:10.1378/chest.130.4.1082 · Cited by 97
Pharmacology of airway inflammation in asthma and COPD
Caramori, G., & Adcock, I. M. (2003) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/s1094-5539(03)00070-1 · Cited by 95
Epidemiology and Management of Common Pulmonary Diseases in Older Persons
Akgun, K. M., Crothers, K. A., & Pisani, M. A. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr251 · Cited by 95
Treatment of asthma with nebulized lidocaine: A randomized, placebo-controlled study
Hunt, L. W., Frigas, E., Butterfield, J. H., Kita, H., Blomgren, J., Dunnette, S. L., Offord, K. P., & Gleich, G. J. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.02.039 · Cited by 93
Overview of the pharmacogenetics of asthma treatment
Weiss, S. T., Litonjua, A. A., Lange, C., Lazarus, R. M., Liggett, S. B., Bleecker, E. R., & Tantisira, K. G. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500387 · Cited by 92
Secondary osteoporosis: Underlying disease and the risk for glucocorticoid-induced osteoporosis
Boling, E. P. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90001-x · Cited by 89
Nixon, J. V., Newbold, P., Mustelin, T., Anderson, G. P., & Kolbeck, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.016 · Cited by 83
Storms, W. W., Chervinsky, P., Ghannam, A. F., Bird, S. R., Hustad, C. M., & Edelman, J. M. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.05.008 · Cited by 82
Brandenburg, V. M., Politt, D., Ketteler, M., Faßbender, W. J., Heussen, N. M., Westenfeld, R., Freuding, T., Floege, J., & Ittel, T. H. (2004) · Transplantation · doi:10.1097/01.tp.0000131990.13277.28 · Cited by 80
Long-Term Safety of Fluticasone Propionate and Nedocromil Sodium on Bone in Children With Asthma
Roux, C., Kolta, S., Desfougères, J. L., Minini, P., & Bidat, É. (2003) · PEDIATRICS · doi:10.1542/peds.111.6.e706 · Cited by 79
de Vries, F., Pouwels, S., Lammers, J. J., Leufkens, H. G. M., Bracke, M., Cooper, C. C., & van Staa, T. P. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01754.x · Cited by 79
Safety of Inhaled Corticosteroids
Tattersfield, A. E., Harrison, T. W., Hubbard, R., & Mortimer, K. J. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200402-016ms · Cited by 76
Choi, H. K., & Seeger, J. D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21329 · Cited by 74
Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review
Patel, R., Naqvi, S. A., Griffiths, C., & Bloom, C. I. (2020) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000756 · Cited by 73
Long-term Use of Inhaled Corticosteroids in COPD and the Risk of Fracture
Gonzalez, A. V., Coulombe, J., Ernst, P., & Suissa, S. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.07.002 · Cited by 67
Safety of intranasal corticosteroids in acute rhinosinusitis
Demoly, P. M. (2008) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2007.11.004 · Cited by 67
How to set up a severe asthma service
McDonald, V. M., Vertigan, A. E., & Gibson, P. G. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02012.x · Cited by 64
Corticosteroid-Associated Tendinopathies
Blanco, I., hl, S. K. H., & Schlienger, R. G. (2005) · Drug Safety · doi:10.2165/00002018-200528070-00005 · Cited by 63
Singh, S., & Loke (2010) · International Journal of COPD · doi:10.2147/copd.s6942 · Cited by 62
Hadjidakis, D., Tsagarakis, S., Roboti, C., Sfakianakis, M., Iconomidou, V., Raptis, S. A., & Thalassinos, N. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01676.x · Cited by 60
Diagnosis and Management of Asthma in Older Adults
Chotirmall, S. H., Watts, M., Branagan, P., Donegan, C. F., Moore, A. R., & McElvaney, N. G. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02216.x · Cited by 59
Safety of the Newer Inhaled Corticosteroids in Childhood Asthma
Randell, T. L., Donaghue, K. C., Ambler, G. R., Cowell, C. T. C. T., Fitzgerald, D. A., & van Asperen, P. P. (2003) · Pediatric Drugs · doi:10.2165/00128072-200305070-00005 · Cited by 59
Side-effects of fluticasone in asthmatic children: no effects after dose reduction
Visser, M. J., van der Veer, E., Postma, D. S., Arends, L. R., de Vries, T. W., Brand, P. L. P., & Duiverman, E. J. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00023904 · Cited by 59
Dubois, E. F., Roïder, E., Dekhuijzen, P. N. R., Zwinderman, A. E., & Schweitzer, D. H. (2002) · CHEST Journal · doi:10.1378/chest.121.5.1456 · Cited by 59
van der Burgh, A. C., de Keyser, C. E., Zillikens, M. C., & Stricker, B. H. C. (2021) · Drugs · doi:10.1007/s40265-021-01625-8 · Cited by 60
Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases
Gluck, O. S., & Colice, G. (2004) · CHEST Journal · doi:10.1378/chest.125.5.1859 · Cited by 57
Metabolic Disorders in Chronic Lung Diseases
Παπαϊωάννου, Ο., Karampitsakos, Τ., Barbayianni, I., Chrysikos, S., Xylourgidis, N., Tzilas, V., Bouros, D. E., Aidinis, V., & Tzouvelekis, A. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2017.00246 · Cited by 58
Glucocorticoid Pathways in Chronic Obstructive Pulmonary Disease Therapy
Adcock, I. M., & Ito, K. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-035sr · Cited by 56
Glucocorticoid-induced osteoporosis
Tamura, Y., Okinaga, H., & Takami, H. E. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.08.018 · Cited by 56
Glucocorticoid-induced osteoporosis
Berris, K. A. K., Repp, A. L., & Kleerekoper, M. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f15407 · Cited by 56
McKeown, E., Bykerk, V. P., de Leon, F., Bonner, A., Thorne, C., Hitchon, C. A., Boire, G., Haraoui, B. P., Ferland, D., Keystone, E. C., et al. (2012) · Rheumatology · doi:10.1093/rheumatology/kes079 · Cited by 52
Glucocorticoid-induced osteoporosis
Silverman, S. L., & Lane, N. E. (2009) · Current Osteoporosis Reports · doi:10.1007/s11914-009-0005-4 · Cited by 50
Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures
Gourlay, M. L., Franceschini, N., & Sheyn, Y. (2006) · Clinical Rheumatology · doi:10.1007/s10067-006-0315-1 · Cited by 50
Effects of inhaled corticosteroids on bone
Mortimer, K. J., Harrison, T. W., & Tattersfield, A. E. (2005) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61280-x · Cited by 50
Glucocorticoid-induced osteoporosis: pathogenesis, diagnosis, and management
McIlwain, H. H. (2003) · Preventive Medicine · doi:10.1016/s0091-7435(02)00019-1 · Cited by 49
Kerezoudis, P., Rinaldo, L., Alvi, M. A., Hunt, C., Qu, W., Maus, T. P., & Bydon, M. (2017) · Pain Medicine · doi:10.1093/pm/pnx324 · Cited by 48
Kaliner, M. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.03.003 · Cited by 47
Dolgos, S., Hartmann, A., Isaksen, G. A., Simonsen, S., Bjørtuft, Ø., Boberg, K. M., & Bollerslev, J. (2010) · Clinical Transplantation · doi:10.1111/j.1399-0012.2010.01231.x · Cited by 46
Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period
Putman, M. S., Baker, J. F., Uluer, A., Herlyn, K., Lapey, A., Sicilian, L., Tillotson, A. P., Gordon, C. M., Merkel, P. A., & Finkelstein, J. S. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.01.011 · Cited by 46
Glucocorticoid-Induced osteoporosis: clinical and therapeutic aspects
Mazziotti, G., Giustina, A., CANALIS, E. M., & Bilezikian, J. P. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800028 · Cited by 45
Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomised trial
Fogarty, A., Lewis, S., Scrivener, S., Antoniak, M. D., Pacey, S. J., Pringle, M., & Britton, J. R. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.03.038 · Cited by 45
Bielory, L., Blaiss, M. S., Fìneman, S. M., Ledford, D. K., Lieberman, P., Simons, F. E. R., Skoner, D. P., & Storms, W. W. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63545-4 · Cited by 44
Kemp, J. P., Osur, S. L., Shrewsbury, S. B., Herje, N. E., Duke, S. P., Harding, S. M., Faulkner, K. G., & Crim, C. C. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.4.458 · Cited by 43
Rideout, C. A., Linden, W., & Barr, S. I. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.6.628 · Cited by 42
The Skeletal Effects of Inhaled Glucocorticoids
Sutter, S. A., & Stein, E. M. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0308-1 · Cited by 42
Skoner, D. P. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.07.043 · Cited by 41
Safety of inhaled corticosteroids in the treatment of persistent asthma.
Peters, S. P. (2006) · PubMed Central · Cited by 41
Information Retrieval System for Medical Narrative Reports
Rokach, L., Maimon, O., & Averbuch, M. (2004) · Lecture notes in computer science · doi:10.1007/978-3-540-25957-2_18 · Cited by 41
Al-Shoha, A., Rao, D. S., Schilling, J., Peterson, E. L., & Mandel, S. S. (2012) · Spine · doi:10.1097/brs.0b013e318270280e · Cited by 40
The role of pharmacogenomics in improving the management of asthma
Kazani, S. D., Wechsler, M. E., & Israel, E. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.12.014 · Cited by 40
Self-citationBuchwald, P. (2007) · Steroids · doi:10.1016/j.steroids.2007.10.001 · Cited by 40
Dubois, E. F., Wagemans, M. F. M., Verdouw, B. C., Zwinderman, A. H., van Boxtel, C. J., Dekhuijzen, P. N. R., & Schweitzer, D. H. (2003) · Clinical Rheumatology · doi:10.1007/s10067-002-0648-3 · Cited by 40
Huang, Z., Wang, Q., Zhang, T., Fu, Y., & Wang, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111711 · Cited by 38
Henríquez, M. S., Saavedra, P., Valero, C., Guañabens, N., Nogués, X., del Pino‐Montes, J., Mosquera, J., Alegre, J., Gómez‐Alonso, C., Muñoz‐Torres, M., et al. (2006) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2005.11.005 · Cited by 37
Managing Older Patients with Coexistent Asthma and Chronic Obstructive Pulmonary Disease
McDonald, V. M., Higgins, I., & Gibson, P. G. (2012) · Drugs & Aging · doi:10.1007/s40266-012-0042-z · Cited by 38
The effects of corticosteroids on bone growth and bone density
Weldon, D. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60135-4 · Cited by 37
Development of lumbar bone mineral density in the late course after kidney transplantation
Brandenburg, V. M., Ketteler, M., Faßbender, W. J., Heussen, N. M., Freuding, T., Floege, J., & Ittel, T. H. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36345 · Cited by 36
Metadata
- Authors
- Israel, E., Banerjee, T. R., Fitzmaurice, G. M., Kotlov, T. V., LaHive, K., & LeBoff, M. S.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Harvard Pilgrim Health Care (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-09-27
- Volume
- 345
- Issue
- 13
- Pages
- 941-947
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2061819610
- Cited by
- 303
- References
- 25
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 5 · 2019: 3 · 2018: 10 · 2017: 9 · 2016: 11 · 2015: 12 · 2014: 6 · 2013: 6 · 2012: 8
- FWCI
- 32.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (HL0843)
- National Center for Research Resources (M01 RR 02635, M01RR002635)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- inhaled corticosteroids, bone mineral density, bone loss, asthma, premenopausal women, triamcinolone acetonide, dose-response relationship, hip bone, glucocorticoid-induced osteoporosis, bone turnover markers, osteocalcin, parathyroid hormone, urinary N-telopeptide, adrenal function
- MeSH terms
- Administration, Inhalation, Adolescent, Adult, Asthma, Dose-Response Relationship, Drug, Female, Femur, Glucocorticoids, Humans, Lumbar Vertebrae, Middle Aged, Pelvic Bones, Triamcinolone Acetonide, Cohort Studies, Bone Density, Premenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
